Global Recombinant Vaccine Market Report By Product (Subunit Recombinant Vaccine, Attenuated Recombinant Vaccine And Vector Recombinant Vaccine), End-User (Recombinant Human Vaccine And Animal Recombinant Vaccine) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210560
February 2019
Report Formats:
As per this study the Global Recombinant Vaccine Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%. By volume, the market was estimated XX.X KT in 2018 and is expected to reach XX.X KT by 2025 with a CAGR of X.X%.
Recombinant vaccine refers to the biological suspension developed using recombinant DNA technology. The recombinant vaccine is produced by introducing genetic material of dead or attenuated antigen into the host body through a vector that results in stimulation of immune response. It is useful to offer resistance to malaria, typhoid, allergies, cancer, and various infectious diseases such as Ebola, Flu, HPV, measles, smallpox, etc.
Market Dynamics
Growing health threat on account of widespread of infectious diseases and increasing prevalence of cancer is driving the market growth. Rise in immunization programs by the government to promote resistant to diseases is further fueling the market demand. Ongoing advancement in the field of immunology, molecular biology, biochemistry, genomics, and proteomics is again boosting the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of recombinant vaccine.
Market Segmentation
The broad recombinant vaccine market has been sub-grouped into product and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product
- Subunit Recombinant Vaccine
- Attenuated Recombinant Vaccine
- Vector Recombinant Vaccine
By End-User
- Recombinant Human Vaccine
- Animal Recombinant Vaccine
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for recombinant vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Recombinant Vaccine Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the recombinant vaccine market include Bayer AG, Bharat Biotech, GlaxoSmithKline Plc., Green Cross Corporation, Merck & Co., Inc., Novartis AG, Pfizer Inc., Protein Science Corporation and Sanofi S A. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1. INTRODUCTION
- Introduction To Recombinant Vaccine
- Report Description
- Objectives Of The Study
- Assumptions
- Research Scope
- Research Methodology
- Data Source
2. EXECUTIVE SUMMARY
- Market Highlight
- Global Recombinant Vaccine Market: Snapshot
3. MARKET ANALYSIS
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Value Chain Analysis
4. RECOMBINANT VACCINE MARKET ANALYSIS BY PRODUCT
- Market In Subunit Recombinant Vaccine
- Market In Attenuated Recombinant Vaccine
- Market In Vector Recombinant Vaccine
5. RECOMBINANT VACCINE MARKET ANALYSIS BY END-USER
- Market In Recombinant Human Vaccine
- Market In Animal Recombinant Vaccine
6. RECOMBINANT VACCINE MARKET ANALYSIS BY GEOGRAPHY
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
7. COMPETITIVE LANDSCAPE OF THE RECOMBINANT VACCINE COMPANIES
- Market Competition
- Partnerships/Collaborations/Agreements
- Mergers And Acquisitions
- New Product Launches
- Other Developments
8. COMPANY PROFILES OF THE RECOMBINANT VACCINE INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- Bayer AG
- Bharat Biotech
- GlaxoSmithKline Plc.
- Green Cross Corporation
- Merck & Co., Inc
- Novartis AG
- Pfizer Inc.
- Protein Science Corporation
- Sanofi S A.
* Tentative TOC
LIST OF TABLES
Table 1. Market Highlights Of Recombinant Vaccine
Table 2. Global Recombinant Vaccine Market By Product
Table 3. Global Recombinant Vaccine Market By End-User
Table 4. Global Recombinant Vaccine Market By Geography
Table 5. North America Recombinant Vaccine Market
Table 6. Europe Recombinant Vaccine Market
Table 7. Asia Pacific Recombinant Vaccine Market
Table 8. Latin America Recombinant Vaccine Market
Table 9. Middle East And Africa Recombinant Vaccine Market
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Recombinant Vaccine Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Recombinant Vaccine
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Recombinant Vaccine Market By Product
Fig. 8. Global Recombinant Vaccine Market By End-User
Fig. 9. Global Recombinant Vaccine Market By Geography
Fig. 10. North America Recombinant Vaccine Market
Fig. 11. Europe Recombinant Vaccine Market
Fig. 12. Asia Pacific Recombinant Vaccine Market
Fig. 13. Latin America Recombinant Vaccine Market
Fig. 14. Middle East And Africa Recombinant Vaccine Market
Fig. 15. Market Share Of Recombinant Vaccine Companies
Fig. 16. Recent Developments In Recombinant Vaccine Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
